These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 17521943)
21. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Eder AF; Kennedy JM; Dy BA; Notari EP; Weiss JW; Fang CT; Wagner S; Dodd RY; Benjamin RJ; Transfusion; 2007 Jul; 47(7):1134-42. PubMed ID: 17581147 [TBL] [Abstract][Full Text] [Related]
22. Problem of bacterial contamination in platelet concentrates. Mathai J Transfus Apher Sci; 2009 Oct; 41(2):139-44. PubMed ID: 19744888 [TBL] [Abstract][Full Text] [Related]
23. Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004. Yomtovian RA; Palavecino EL; Dysktra AH; Downes KA; Morrissey AM; Bajaksouzian S; Pokorny MA; Lazarus HM; Jacobs MR Transfusion; 2006 May; 46(5):719-30. PubMed ID: 16686839 [TBL] [Abstract][Full Text] [Related]
24. Oxygen measurements in platelet fluids - a new non-invasive method to detect bacterial contaminations in platelets. Mueller MM; Hourfar MK; Huber E; Sireis W; Weichert W; Seifried E; Tonn T; Schmidt M Transfus Med; 2012 Jun; 22(3):211-6. PubMed ID: 22462725 [TBL] [Abstract][Full Text] [Related]
25. Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and red cell concentrates. Corash L Dev Biol (Basel); 2000; 102():115-23. PubMed ID: 10794098 [TBL] [Abstract][Full Text] [Related]
26. Proteome changes in platelets after pathogen inactivation--an interlaboratory consensus. Prudent M; D'Alessandro A; Cazenave JP; Devine DV; Gachet C; Greinacher A; Lion N; Schubert P; Steil L; Thiele T; Tissot JD; Völker U; Zolla L Transfus Med Rev; 2014 Apr; 28(2):72-83. PubMed ID: 24685438 [TBL] [Abstract][Full Text] [Related]
27. Platelet transfusion reactions: febrile nonhemolytic reaction or bacterial contamination? Diagnosis, detection, and current preventive modalities. Sharma AD; Grocott HP J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):460-6. PubMed ID: 10972618 [No Abstract] [Full Text] [Related]
28. Bacterial contamination of platelet concentrates produced in New Zealand. Dickson M; Dinesh D N Z Med J; 2013 May; 126(1374):12-21. PubMed ID: 23799378 [TBL] [Abstract][Full Text] [Related]
29. Mirasol PRT system inactivation efficacy evaluated in platelet concentrates by bacteria-contamination model. Jocić M; Trkuljić M; Jovicić D; Borovcanin N; Todorović M; Balint B Vojnosanit Pregl; 2011 Dec; 68(12):1041-6. PubMed ID: 22352265 [TBL] [Abstract][Full Text] [Related]
30. Bacterial contamination of whole-blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross. Benjamin RJ; Kline L; Dy BA; Kennedy J; Pisciotto P; Sapatnekar S; Mercado R; Eder AF Transfusion; 2008 Nov; 48(11):2348-55. PubMed ID: 18657074 [TBL] [Abstract][Full Text] [Related]
31. Feasibility of implementing an automated culture system for bacteria screening in platelets in the blood bank routine. Castro E; Bueno JL; Barea L; González R Transfus Med; 2005 Jun; 15(3):185-95. PubMed ID: 15943703 [TBL] [Abstract][Full Text] [Related]
33. Prevention of transfusion of platelet components contaminated with low levels of bacteria: a comparison of bacteria culture and pathogen inactivation methods. Nussbaumer W; Allerstorfer D; Grabmer C; Rheinschmidt M; Lin L; Schönitzer D; Lass-Flörl C Transfusion; 2007 Jul; 47(7):1125-33. PubMed ID: 17581146 [TBL] [Abstract][Full Text] [Related]
35. [Pathogen inactivation in platelet concentrates: the French experience]. Cazenave JP Transfus Clin Biol; 2011 Aug; 18(4):478-84. PubMed ID: 21719338 [TBL] [Abstract][Full Text] [Related]
36. Frequency of bacterial contamination of platelet concentrates before and after introduction of diversion method in Japan. Satake M; Mitani T; Oikawa S; Nagumo H; Sugiura S; Tateyama H; Awakihara S; Mitsutomi Y; Muraoka M; Tadokoro K Transfusion; 2009 Oct; 49(10):2152-7. PubMed ID: 19500321 [TBL] [Abstract][Full Text] [Related]
37. Rapid and sensitive detection of viable bacteria in contaminated platelet concentrates using a newly developed bioimaging system. Motoyama Y; Yamaguchi N; Matsumoto M; Kagami N; Tani Y; Satake M; Nasu M Transfusion; 2008 Nov; 48(11):2364-9. PubMed ID: 18680549 [TBL] [Abstract][Full Text] [Related]
38. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Murphy WG; Foley M; Doherty C; Tierney G; Kinsella A; Salami A; Cadden E; Coakley P Vox Sang; 2008 Jul; 95(1):13-9. PubMed ID: 18393945 [TBL] [Abstract][Full Text] [Related]